Douglas Stickle, PhD, DABCC, FACB

Douglas Stickle, PhD, DABCC, FACB

Contact Dr. Stickle

117 South 11th Street
401 Pavilion
Philadelphia, PA 19107

(215) 503-5837
(215) 923-3523 fax

Most Recent Peer-reviewed Publications

  1. High prevalence of xylazine among fentanyl screen-positive urines from hospitalized patients, Philadelphia, 2021
  2. Intraperitoneal pharmacokinetics of vancomycin in patients on automated peritoneal dialysis
  3. Drug-Drug Interaction Study of Apixaban with Cyclosporine and Tacrolimus in Healthy Volunteers
  4. Use of a model for A1c formation to estimate average glucose operative between short-interval measurements of %A1c
  5. Model analysis of bidirectional interference in two-stage labeled-ligand immunoassays
  6. Average glucose from hemoglobin A1c for altered red blood cell lifetimes: Predictions based on a model for hemoglobin A1c formation
  7. Distribution of serum concentrations reported for macroenzyme aspartate aminotransferase (macro-AST)
  8. Observation of a positive interference in LC-MS/MS measurement of d6-25-OH-vitamin D3
  9. Validation, quality control, and compliance practice for mass spectrometry assays in the clinical laboratory
  10. Estimation of hematocrit in filter paper dried bloodspots by potassium measurement: Advantage of use of perimeter ring samples over circular center sub-punch samples
  11. Model analysis of effect of canagliflozin (Invokana), a sodium-glucose cotransporter 2 inhibitor, to alter plasma 1,5-anhydroglucitol
  12. Non-linearity within the primary measurement range of a lipase assay as the cause of a gap in the interpatient lipase results distribution
  13. Interpatient distributions of bloodspot area per fixed volume of application: Comparison between filter paper and non-cellulose dried matrix spotting cards
  14. Should all screen-positive elevated blood lead (EBL) samples be retested before reporting?
  15. How well can urine hydrocodone measurements discriminate between different hydrocodone prescription dosage rates?
  16. Decreasing the cutoff for elevated blood lead (ebl) can decrease the screening sensitivity for EBL
  17. Receiver-operating characteristics of adjusted urine measurements of oxycodone plus metabolites to distinguish between three different rates of oxycodone administration
  18. Predicted effects of proposed tightened acceptance criterion for Pb proficiency testing (PT) on PT sample pass rates for Pb point-of-care testing
  19. Investigation of a slope discontinuity in a patients' results distribution for D-dimer
  20. Measurement of filter paper bloodspot lead by inductively coupled plasma-mass spectrometry (ICP-MS).
  21. New onset of heterophilic antibody interference in prostate-specific antigen measurement occurring during the period of post-prostatectomy prostate-specific antigen monitoring
  22. Increased perimeter red cell concentration in filter paper bloodspot samples is consistent with constant-load size exclusion chromatography occurring during application
  23. 1,5-anhydroglucitol monitoring in diabetes: A mass balance perspective
  24. A survey of apparent blood volumes and sample geometries among filter paper bloodspot samples submitted for lead screening
  25. Predicted effects of hemoglobin A1c assay precision on a patient population distribution of serial hemoglobin A1c difference values